Medication Options for Treatment of Stimulant Use Disorders: Optimistic Update and New Research

Distance Training Glossary | Print Version | Email This Page To A Friend

Training Details

Event Dates and Timeframe
Tuesday, March 2, 2021
Location and Delivery Method
Delivery Method
Online / Web Delivered
Cost Range

Host And Instructor

National Conference on Addiction Disorders
Marc Fishman, MD
class/provider logo image

Training Overview Description

Overdose deaths associated with illicit stimulants (cocaine and methamphetamine) have surged in the past eight years, according to a recent study by the National Institutes for Health (NIH). While there are currently no FDA-approved medications for the treatment of individuals who are dependent upon methamphetamine, new treatments utilizing readily available medications are showing encouraging empirical support.

Event-specific Details

This webinar will examine the latest groundbreaking research in the context of current increases in stimulant use. Marc Fishman, MD, medical director of Maryland Treatment Centers, a member of the psychiatry faculty of the Johns Hopkins University School of Medicine, and a member of the National Council’s Medical Director Institute will share his expertise as an addiction medicine specialist to bring the latest information to help you:

• Understand the current epidemiology of methamphetamine use in the U.S.
• Address the most common clinical challenges in treating people with stimulant use disorders.
• Explore new research that provides evidence for potential treatment of stimulant use disorder treatment.